{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:42:43Z","timestamp":1758814963848},"reference-count":31,"publisher":"Kurume Medical Journal","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2020,12,31]]},"DOI":"10.2739\/kurumemedj.ms674002","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T06:35:31Z","timestamp":1669790131000},"page":"163-170","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcomes of Intraoperative Radiotherapy, Postoperative Radiotherapy, and Definitive Radiotherapy for Non-metastatic Pancreatic Cancer"],"prefix":"10.2739","volume":"67","author":[{"given":"TAKESHI","family":"YANAGI","sequence":"first","affiliation":[{"name":"Department of Proton, Narita Memorial Proton Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NATSUKO","family":"TAKAMA","sequence":"additional","affiliation":[{"name":"Department of Radiology, Konan Kosei Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ERIKO","family":"KATO","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nagoya Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUMIYA","family":"BABA","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nagoya West Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASANORI","family":"KITASE","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kariya Toyota Sogo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASASHI","family":"SHIMOHIRA","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROZUMI","family":"SAWAI","sequence":"additional","affiliation":[{"name":"Department of Surgery, Narita Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOKATSU","family":"KATO","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOICHI","family":"MATSUO","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUTA","family":"SHIBAMOTO","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1445","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Siegel R, Ma J, Zou Z, and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29.","DOI":"10.3322\/caac.21208"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008; 26:3503-3510.","DOI":"10.1200\/JCO.2007.15.8469"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Reni M, Panucci MG, Ferreri AJ, Balzano G, Passoni P et al. Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2001; 50:651-658.","DOI":"10.1016\/S0360-3016(01)01470-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shibamoto Y, Manabe T, Baba N, Sasai K, Takahashi M et al. High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 1990; 19:605-611.","DOI":"10.1016\/0360-3016(90)90486-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cameron JL, Riall TS, Coleman J, and Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244:10-15.","DOI":"10.1097\/01.sla.0000217673.04165.ea"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C et al. Phase III trial comparing intensive induction chemoradiotherapy (60Gy, in fusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD\/SFRO study. Ann Oncol 2008; 19:1592-1599.","DOI":"10.1093\/annonc\/mdn281"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, and Moertel CG. Treatment of locally unresectable carcinoma: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil\u2014an Eastern Cooperative Oncology Group study. J Clin Oncol 1985; 3:373-378.","DOI":"10.1200\/JCO.1985.3.3.373"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shibamoto Y, Manabe T, Ohshio G, Sasai K, Nishimura Y et al. High-dose intraoperative radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 1996; 34:57-63.","DOI":"10.1016\/0360-3016(95)00014-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fuji T, Yamada S, Murotani K, Kanda M, Sugimoto H et al. Inverse probability of treatment weighting analysis of upfront surgery versus neoadjuvant chemoradiotherapy followed by surgery for pancreatic adenocarcinoma with arterial abutment. Medicine 2015; 94:e1647.","DOI":"10.1097\/MD.0000000000001647"},{"key":"10","unstructured":"10. Japan Pancreas Society. Guideline for pancreatic cancer based on evidence. Kanehara-Shuppan, Tokyo, pp78-80, 2019."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Loehrer PJ Sr, Feng Y, Cardenes H, Wagner L, Brell JB et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol 2011; 29:4105-4112.","DOI":"10.1200\/JCO.2011.34.8904"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988; 80:751-755.","DOI":"10.1093\/jnci\/80.10.751"},{"key":"13","unstructured":"13. Hazel JJ, Thirlwell MP, Huggins M, Maksymiuk A, and MacFarlane JK. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial. J Can Assoc Radiol 1981; 32:164-165."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hammel P, Hugel F, van Laethem JL, Goldstein D, Glimelius B et al. Effect of Chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial. JAMA 2016; 315:1844-1853.","DOI":"10.1001\/jama.2016.4324"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kinoshita T, Uesaka K, Shimizu Y, Sakamoto H, Kimura W et al. Effects of adjuvant intra-operative radiation therapy after curative resection in pancreatic cancer patients: Results of a randomized study by 11 institutions in Japan. J Clin Oncol 2009; 27:15s.","DOI":"10.1200\/jco.2009.27.15_suppl.4622"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K et al. Intraoperative radiotherapy for resected pancreatic cancer: multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys 2010; 77:734-742.","DOI":"10.1016\/j.ijrobp.2009.09.010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jingu K, Tanabe T, Nemoto K, Ariga H, Umezawa R et al. Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan. Int J Radiat Oncol Biol Phys 2012; 83:e507-e511.","DOI":"10.1016\/j.ijrobp.2012.01.024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP et al. Fluorouracil based chemoradiation with either gemcitabine or fluorouracil chemotherapy following resection of pancreatic adenocarcinoma: 5-year analysis of the US intergroup\/RTOG 9704 phase III trial. Ann Sug Oncol 2011; 18:1319-1326.","DOI":"10.1245\/s10434-011-1630-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Morganti AG, Falconi M, Stiphout RGPM, Mattiucci GC, Alfieri S et al. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Int J Radiat Oncol Biol Phys 2014; 90:911-917.","DOI":"10.1016\/j.ijrobp.2014.07.024"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kinsella TJ and Sindelar WF. Intraoperative radiotherapy for pancreatic carcinoma. Experimental and clinical studies. Cancer 1996; 78:598-604.","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<598::AID-CNCR40>3.0.CO;2-R"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Morak MLM, Gaast A, Incrocci L, Dekken H, Hermans JJ et al. Adjunvant intra-arterial chemotherapy and radiotherapy versus surgery alone, resectable pancreatic and periampullary cancer. Ann Surg 2008; 248:1031-1041.","DOI":"10.1097\/SLA.0b013e318190c53e"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Messick C, Hardacre JM, McGee MF, Siegel CT, Stellato TA et al. Early experience with intraoperative radiotherapy in patients with resected pancreatic adenocarcinoma. Am J Surg 2008; 195:308-311.","DOI":"10.1016\/j.amjsurg.2007.12.024"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Showarter TN, Rao AS, Rani Anne P, Rosato EL, Andrel J et al. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Ann Surg Oncol 2009; 16:2116-2122.","DOI":"10.1245\/s10434-009-0498-1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Abe T, Ito K, Agawa S, and Konishi T. Treatment and complications for pancreatic cancer. Jpn J Gastroenterol Surg 2001; 34:459-564.","DOI":"10.5833\/jjgs.34.459"},{"key":"25","unstructured":"25. Yasue M. Pancreatic cancer. Kan tan sui 1994; 28:667-673 (in Japanese)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shibamoto Y, Sugie C, Ito M, and Ogino H. The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: From hypoxic cell sensitizers to radiation-activated prodrugs. Expert Opin Pharmacother 2004; 5:2459-2467.","DOI":"10.1517\/14656566.5.12.2459"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Karasawa K, Sunamura M, Okamoto A, Nemoto K, Matsuno S et al. Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: long-term results of a placebo-controlled randomized study. Radiother Oncol 2008; 87:326-330.","DOI":"10.1016\/j.radonc.2008.02.007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shinoto M, Yamada S, Terashima K, Yasuda S, Shioyama Y et al. Carbon ion radiation therapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2016; 95:498-504.","DOI":"10.1016\/j.ijrobp.2015.12.362"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Terashima K, Demizu Y, Hashimoto N, Jin D, Mima M et al. A phase I\/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol 2012; 103:25-31.","DOI":"10.1016\/j.radonc.2011.12.029"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shinoto M, Terashima K, Suefuji H, Matsunobu A, Toyama S et al. A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer. Radiother Oncol 2018; 129:333-339.","DOI":"10.1016\/j.radonc.2018.08.026"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Stocken DD, Buechler MW, Dervenis C, Bassi C, Jeekel H et al. Meta-analysis of randomized adjuvant therapy trial for pancreatic cancer. Br J Cancer 2005; 92:1372-1381.","DOI":"10.1038\/sj.bjc.6602513"}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/67\/4\/67_MS674002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T04:47:52Z","timestamp":1676090872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/67\/4\/67_MS674002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms674002","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"article-number":"MS674002"}}